½ÃÇè°ú¸ñº° °øÁö»çÇ×

  • ½ÃÇè¾È³»
  • ½ÃÇè°ú¸ñº° °øÁö»çÇ×

2026³âµµ Á¦4ȸ Àü¹®¾à»ç ÀڰݽÃÇè °øÁö»çÇ×

- °¨¿° -

1½ÃÇè³»¿ë ±¸¼º ¹× ½ÃÇè½Ã°£ (Àü °ú¸ñ °øÅë»çÇ×)

1)½ÃÇè³»¿ëÀº °øÅ뿵¿ª°ú Àü¹®¿µ¿ªÀ¸·Î ±¸¼ºµÊ.

  • °øÅ뿵¿ª : ÀÇÇÐÅë°è ¹× ÀǤý¾àÇÐ³í¹®ºñÆò
  • Àü¹®¿µ¿ª : °¨¿°

2)½ÃÇè½Ã°£

  • ÃÑ ½ÃÇè½Ã°£ : ½ÃÇèÁغñ ¹× ¾È³», °øÁö½Ã°£ µîÀ» Æ÷ÇÔÇÏ¿© 180ºÐ(3½Ã°£).

2ÃâÁ¦À¯Çü ¹× ¹èÁ¡

1)°øÅ뿵¿ª(ÃÑ20Á¡) : °´°ü½Ä 20¹®Ç× (°¢ 1Á¡)

2)Àü¹®¿µ¿ª(ÃÑ80Á¡) : °´°ü½Ä 80¹®Ç× (°¢ 1Á¡)

  • ¾à¹°¿ä¹ýÀÇ ÀûÀý¼º °ËÅä
  • ¾à¹°¿ä¹ý °ü·Ã ¹®Á¦(drug-related problems) ÆÄ¾Ç ¹× ÇØ°á¹æ¾È Á¦½Ã
  • ȯÀÚ ¸ÂÃãÇü ¾à¹° ¼±Åà ¹× ¾à¹°¿ä¹ý °èȹ ¼ö¸³
  • ¾à¹°¿ä¹ýÀÇ Ä¡·áÈ¿°ú ¹× ¾à¹° ÀÌ»ó¹ÝÀÀ ¸ð´ÏÅ͸µ
  • ȯÀÚ º¹¾à»ó´ã ¹× ±³À°
  • Ç×»ýÁ¦ °ü¸®¿¡¼­ ¾à»çÀÇ ¿ªÇÒ µî

3ÃâÁ¦¹üÀ§

1)°øÅ뿵¿ª ÃâÁ¦¹üÀ§ : ÀǾàÅë°èÀÇ ±âº»°³³ä ¹× À̸¦ Ȱ¿ëÇÑ ³í¹®Çؼ®°ú ºñÆò, ÀÓ»óÀû¿ë µî¿¡ °üÇÑ ¹®Ç×À¸·Î ÀÌ·ç¾îÁü.

  • ±Ù°Å±â¹ÝÀÇÇÐ(Evidence-Based Medicine) ¹× ±Ù°Å±â¹ÝÀÓ»ó½Ç¹«(Evidence-Based Clinical Practice, EBCP)ÀÇ ÀÌÇØ
  • ÀǾ๮ÇåÀÇ Á¾·ù ¹× Ư¡
  • ÀÓ»óÅë°èÀÇ ±âº» °³³ä
  • ³í¹®Çؼ®°ú ºñÆò, ÀÓ»óÀû¿ë

2)Àü¹®¿µ¿ª ÃâÁ¦¹üÀ§

  • °¨¿°Ä¡·áÀÇ ¿øÄ¢
    • °¨¿°ÀÇ ÀÓ»óÁõ»ó ¹× ÁõÈÄ
    • °¨¿° ¿øÀÎ º´¿øÃ¼ÀÇ È®ÀÎ
    • Ç×»ýÁ¦ÀÇ Ç×±ÕÀÛ¿ë Æò°¡
    • °æÇèÀû Ç×»ýÁ¦ Ä¡·á¿ä¹ýÀÇ ¼±ÅÃ
    • È®Á¤Àû Ç×»ýÁ¦ Ä¡·á¿ä¹ýÀÇ ¼±ÅÃ
    • Ç×»ýÁ¦ ¾à¹°Ä¡·á Æò°¡
  • °¨¿°Áúȯ
    • »ó±âµµ°¨¿°
    • Æó·Å
    • ÀÎÇ÷翣ÀÚ
    • ¿¹¹æÁ¢Á¾
    • °áÇÙ
    • ÁßÃ߽Űæ°è°¨¿°
    • °¨¿°½É³»¸·¿°
    • °ñ°üÀý°¨¿°
    • ÇǺΡ¤¿¬Á¶Á÷ °¨¿°
    • ¿ä·Î°¨¿°
    • À§Àå°ü¡¤º¹°­³» °¨¿°
    • ¼º¸Å°³°¨¿°
    • Áø±Õ°¨¿°
    • ¼ö¼ú ÈÄ °¨¿° ¿¹¹æ
    • »ç¶÷¸é¿ª°áÇ̹ÙÀÌ·¯½º°¨¿° ¹× ±âȸ°¨¿°
    • ¸é¿ªÀúÇÏ °ü·Ã ±âȸ°¨¿°
    • ¸Å°³Ã¼ °¨¿°º´
  • Ç×»ýÁ¦ ½ºÆ©¾îµå½Ê ÇÁ·Î±×·¥(antimicrobial stewardship program)

4Âü°í¹®Çå

1)Àü °ú¸ñ °øÅë Âü°í¹®Çå

°¡)¾à¹°Ä¡·áÇÐ °ü·Ã Âü°í¹®Çå

  • Haines ST, Nolin TD, Ellingrod VL, Holle LM, Cocohoba J, Posey LM. DiPiro ¡®s Pharmacotherapy: A Pathophysiologic Approach. 13th ed., 2026.
  • Schwinghammer TL, Koehler JM, Borchert JS, Slain D, Park SK, eds. Pharmacotherapy Casebook: A Patient-Focused Approach. 12th ed., 2023.
  • Zeind CS, Carvalho MG, Cheng JW, Zaiken K, LaPointe T, eds. Applied Therapeutics: The Clinical Use of Drugs. 12th ed., 2023.
  • Chisholm-Burns MA, Schwinghammer TL, Malone PM, Kolesar JM, Bookstaver PB, Lee KC. Pharmacotherapy Principles & Practice. 6th ed., 2022.
  • Çѱ¹ÀÓ»ó¾àÇÐȸ. ¾à¹°Ä¡·áÇÐ Á¦6°³Á¤. ½ÅÀϺϽº. 2025

³ª)°øÅ뿵¿ª(ÀÇÇÐÅë°è ¹× ÀǤý¾àÇÐ³í¹®ºñÆò) °ü·Ã Âü°í¹®Çå

  • ¾à±¹½Ç¹«ºÐ°úȸ, ¾à·áÁ¤º¸ÇÐ, ½ÅÀϺϽº, 2021³â, Section III, Á¦ 9-13Àå, 16Àå
  • ¾à±¹½Ç¹«ºÐ°úȸ, ÀÓ»ó½Ç¹«¾àÇÐ, ½ÅÀϺϽº, 2024³â, 27Àå, 29Àå
  • Guyatt G, Rennie D, Meade MO & Cook DJ. Users¡¯ Guides to the Medical Literature: A Manual for Evidence-Based Clinical Practice. 3rd ed., New York, USA: McGraw Hill Education & The JAMA Network. 2015.
  • DiCenzo R, ed. Clinical Pharmacist's Guide to Biostatistics and Literature Evaluation. 2nd ed., Lenexa, KS, USA: American College of Clinical Pharmacy. 2015.
  • Browner WS, Thomas B Newman TB, Cummings SR. Designing Clinical Research. 5th ed. Wolters Kluwer. 2022.
  • Malone PM, Witt BA, Malone MJ, Peterson DM. Drug Information: A Guide for Pharmacists, 7th ed. McGraw Hill. 2022.

2)Àü¹®¿µ¿ª °ü·Ã Âü°í¹®Çå

  • VancomycinTDM
    • (¹Ì±¹)ASHP/PIDS/SIDP/IDSA revised consensus guideline and review for therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections:
      https://www.idsociety.org/practice-guideline/vancomycin/
  • ´ÙÁ¦³»¼º ±×¶÷À½¼º±Õ ¾à¹°¿ä¹ý
    • (¹Ì±¹) IDSA 2026 guidance on the treatment of antimicrobial resistant Gram-negative infections:
      https://www.idsociety.org/practice-guideline/amr-guidance/
  • »ó±âµµ°¨¿°
    • (±¹³») ¼ºÀÎ ±Þ¼º »ó±âµµ °¨¿° Ç×»ýÁ¦ »ç¿ëÁöħ:
      https://www.ksat.or.kr/medical/sub01/2017_02_kor.pdf
    • (±¹³») ¼Ò¾Æ ±Þ¼º »ó±âµµ °¨¿° Ç×»ýÁ¦ »ç¿ëÁöħ:
      https://www.junggu.seoul.kr/synap/skin/doc.html?fn=68945_201611151412327760.pdf&rs=/synap/j_457
    • (±¹³») 2014³â °³Á¤ÆÇ À¯¼Ò¾Æ ÁßÀÌ¿° Áø·áÁöħ:
      https://www.otologicalsociety.or.kr/member/file/2014_01.pdf
  • Æó·Å
    • (±¹³») ¼ºÀÎ Áö¿ª»çȸȹµæ Æó·Å Ç×»ýÁ¦ »ç¿ëÁöħ:
      https://www.icdc.incheon.kr/upload/20180523164554454.pdf
    • (±¹³») ¼ºÀκ´¿øÈ¹µæÆó·Å Áø·á ¹× Ç×»ýÁ¦ »ç¿ëÁöħ:
      https://www.daegucidcp.kr/pdf/web/viewer.html?file=%2F%2Fwww.daegucidcp.kr%2Fzbbs%2Fup_file%2Fzbbs_overseas_trip1%2F202310%2F2023+%EC%84%B1%EC%9D%B8%2B%EB%B3%91%EC%9B%90%ED%9A%8D%EB%93%9D%2B%ED%8F%90%EB%A0%B4%2B%EC%A7%84%EB%A3%8C%2B%EB%B0%8F%2B%ED%95%AD%EC%83%9D%EC%A0%9C%2B%EC%82%AC%EC%9A%A9%EC%A7%80%EC%B9%A8.pdf1698039399
    • (¹Ì±¹) ATS/IDSA guidelines for diagnosis and treatment of adults with community-acquired pneumonia:
      https://www.idsociety.org/practice-guideline/community-acquired-pneumonia-cap-in-adults/
    • (¹Ì±¹) IDSA CAP clinical pathway:
      https://www.idsociety.org/globalassets/idsa/practice-guidelines/community-acquired-pneumonia-in-adults/cap-clinical-pathway-final-online.pdf
    • (¹Ì±¹) ATS/IDSA 2016 clinical practice guidelines for the management of adults with hospital-acquired and ventilator-associated pneumonia:
      https://www.idsociety.org/practice-guideline/hap_vap/
  • ÀÎÇ÷翣ÀÚ
    • (±¹³») 2025-2026Àý±â ÀÎÇ÷翣ÀÚ °ü¸® Áöħ(PART II. °¢·Ð):
      https://www.kdca.go.kr/preview/doc.html?fn=175886999870000&rs=/atchmnfl/preview/result/
    • (¹Ì±¹) Clinical practice guidelines for the diagnosis, treatment, chemoprophylaxis, and institutional outbreak management of seasonal influenza: 2018 update by IDSA:
      https://www.idsociety.org/practice-guideline/influenza/
  • ¿¹¹æÁ¢Á¾
    • (±¹³»)¼ºÀÎ ¿¹¹æÁ¢Á¾ ÀÏÁ¤Ç¥:
      https://nip.kdca.go.kr/irhp/infm/goVcntInfo.do?menuLv=1&menuCd=115
    • (±¹³»)¼Ò¾Æ ¿¹¹æÁ¢Á¾ ÀÏÁ¤Ç¥:
      https://nip.kdca.go.kr/irhp/infm/goVcntInfo.do?menuLv=1&menuCd=115
    • (±¹³»)2026³â ±¹°¡¿¹¹æÁ¢Á¾ Áöħ(ÀÇ·á±â°ü¿ë):
      https://www.kdca.go.kr/kdca/2861/subview.do?enc=Zm5jdDF8QEB8JTJGYmJzJTJGa2RjYSUyRjU1JTJGMzA5NjgzJTJGYXJ0Y2xWaWV3LmRvJTNG
    • (±¹³»)´ëÇѰ¨¿°ÇÐȸ ¼ºÀο¹¹æÁ¢Á¾ °³Á¤¾È(2023~2026³â):
      https://www.ksid.or.kr/content/info/vaccine_rule.php
    • (±¹³») 2025³âµµ ¿¹¹æÁ¢Á¾ ´ë»ó °¨¿°º´ °ü¸®Áöħ:
      https://www.kdca.go.kr/preview/doc.html?fn=174771473801900&rs=/atchmnfl/preview/result/
  • °áÇÙ
    • °áÇÙ Áø·áÁöħ(5ÆÇ) (2024):
      https://www.lungkorea.org/bbs/?code=guide&mode=view&number=13403
  • ÁßÃ߽Űæ°è°¨¿°
    • (±¹³») ¼ºÀÎ ¼¼±Õ¼º ¼ö¸·¿°ÀÇ ÀÓ»óÁø·áÁöħ ±Ç°í¾È:
      http://dx.doi.org/10.3947/ic.2012.44.3.140
  • °¨¿°½É³»¸·¿°
    • (±¹³») ½ÉÇ÷°ü°è °¨¿° Áø·áÁöħ ±Ç°í¾È:
      https://doi.org/10.3947/ic.2011.43.2.129
    • (¹Ì±¹) AHA guidelines on infective endocarditis in adults: Diagnosis, antimicrobial therapy, and management of complications:
      https://www.idsociety.org/practice-guideline/endocarditis-management/
    • (¹Ì±¹) Prevention of infective endocarditis:
      https://www.ahajournals.org/doi/full/10.1161/CIRCULATIONAHA.106.183095
  • °ñ°üÀý°¨¿°
    • (±¹³») ±¹³» °ñ°üÀý°¨¿° Ç×±Õ¿ä¹ý ±Ç°í¾È:
      https://icjournal.org/src/sm/ic-46-125-s001.pdf
    • (¹Ì±¹) Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America:
      https://academic.oup.com/cid/article/56/1/e1/415705?login=false
    • (¹Ì±¹) IDSA 2015 clinical practice guidelines for the diagnosis and treatment of native vertebral osteomyelitis in adults:
      https://www.idsociety.org/practice-guideline/vertebral-osteomyelitis/
  • ÇǺΡ¤¿¬Á¶Á÷ °¨¿°
    • (±¹³») ÇǺΠ¿¬Á¶Á÷ °¨¿° Ç×»ýÁ¦ »ç¿ëÁöħ:
      https://www.lungkorea.org/bbs/?code=notice02&mode=view&number=8098
    • (¹Ì±¹) IWGDF/IDSA guidelines on the diagnosis and treatment of diabetes-related foot infections:
      https://www.idsociety.org/practice-guideline/diabetic-foot-infections/
  • ¿ä·Î°¨¿°
    • (±¹³») ¿ä·Î°¨¿° Ç×»ýÁ¦ »ç¿ëÁöħ:
      https://www.ksat.or.kr/medical/file/200406.pdf
    • (¹Ì±¹) IDSA 2025 guideline update on complicated urinary tract infections:
      https://www.idsociety.org/practice-guideline/complicated-urinary-tract-infections/
  • À§Àå°ü¡¤º¹°­³»°¨¿°
    • (±¹³») ¼ÒÈ­±â°è °¨¿° Áø·áÁöħ ±Ç°í¾È:
      https://www.ksat.or.kr/medical/sub01/2010_01_kor.pdf
    • (±¹³») ¼ºÀÎ º¹°­ ³» °¨¿° Ç×»ýÁ¦ »ç¿ëÁöħ:
      https://www.ksat.or.kr/medical/sub01/2022_03_kor.pdf
    • (±¹³») ±Þ¼ºÀ§Àå°ü°è °¨¿° Ç×»ýÁ¦ »ç¿ëÁöħ:
      https://www.ksat.or.kr/medical/sub01/2019_01_kor.pdf
    • (±¹³») 2026´ëÇѰ£ÇÐȸ ¸¸¼ºBÇü°£¿° Áø·á °¡À̵å¶óÀÎ:
      https://www.kasl.org/bbs/?number=6713&mode=view&code=guide&keyfield=&keyword=&category=&gubun=&orderfield=
    • (±¹³») 2025 ´ëÇѰ£ÇÐȸ CÇü°£¿° Áø·á °¡À̵å¶óÀÎ:
      https://www.kasl.org/bbs/?number=6192&mode=view&code=guide&keyfield=&keyword=&category=B&gubun=&orderfield=
    • (¹Ì±¹) Clinical practice guidelines for the management of Clostridioides difficile infection in adults: 2021 update by SHEA/IDSA:
      https://www.idsociety.org/practice-guideline/clostridioides-difficile-2021-focused-update/
  • ¼º¸Å°³°¨¿°
    • (±¹³») ¼º¸Å°³°¨¿° Áø·áÁöħ2023:
      https://www.uti.or.kr/include/pdf/KOREAN_STI_GUIDELINES_2023.pdf
  • Áø±Õ°¨¿°
    • (¹Ì±¹) Clinical practice guideline for the management of candidiasis: 2016 update by IDSA:
      https://www.idsociety.org/practice-guideline/candidiasis/
    • (¹Ì±¹) Clinical practice guideline for the diagnosis and management of aspergillosis: 2016 update by IDSA:
      https://www.idsociety.org/practice-guideline/aspergillosis/
  • ¼ö¼ú ÈÄ °¨¿° ¿¹¹æ
    • (±¹³») 2025³â¼ö¼úÀÇ¿¹¹æÀûÇ×»ýÁ¦»ç¿ëÀûÁ¤¼ºÆò°¡ ¿ä¾ç±â°ü ¼³¸íȸ Ã¥ÀÚ:
      https://www.hira.or.kr/bbs/157/2025/02/BZ202502191207324.pdf
    • (¹Ì±¹) Strategies to prevent surgical site infections in acute-care hospitals: 2022 update:
      https://doi.org/10.1017/ice.2023.67
    • (¹Ì±¹) Clinical practice guidelines for antimicrobial prophylaxis in surgery:
      https://www.ashp.org/surgical-guidelines
  • »ç¶÷¸é¿ª°áÇ̹ÙÀÌ·¯½º°¨¿° ¹× ±âȸ°¨¿°
    • (±¹³») HIV °¨¿°ÀÇ Áø´Ü°ú Ä¡·á:
      https://icjournal.org/src/sm/ic-53-592-s001.pdf
    • (±¹³») HIV °¨¿°ÀÎÀÇ ±âȸ°¨¿°Áõ Ä¡·á¿Í ¿¹¹æ:
      https://www.icjournal.org/src/sm/ic-48-54-s001.pdf
    • (±¹³»)±¹³» HIV ³ëÃâ Àü ¿¹¹æ¿ä¹ý ±Ç°í¾È:
      https://www.icjournal.org/src/sm/ic-49-243-s001.pdf
    • (±¹³») HIV °¨¿°ÀÎ Áø·á¸¦ À§ÇÑ ÀÇ·á±â°ü ±æ¶óÀâÀÌ:
      https://www.ulsancidc.or.kr/kor/?pCode=MN0000019&pg=4&mode=view&idx=2337
    • (¹Ì±¹) Primary care guidance for providers who care for persons with human immunodeficiency virus: 2024 update by the HIV Medicine Association of the Infectious Diseases Society of America:
      https://www.idsociety.org/practice-guideline/primary-care-management-of-people-with-hiv/
    • (¹Ì±¹) Guidelines for the use of antiretroviral agents in adults and adolescents with HIV:
      https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/whats-new
    • (¹Ì±¹) Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV:
      https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/whats-new
    • (¹Ì±¹)Recmmendations for the use of antiretroviral drugs during pregnancy and interventions to reduce perinatal HIV transmission in the United States:
      https://clinicalinfo.hiv.gov/en/guidelines/perinatal/whats-new
  • ¸é¿ªÀúÇÏ °ü·Ã ±âȸ°¨¿°
    • (¹Ì±¹) Prevention and Treatment of Cancer-Related Infections, Version 1.2026, NCCN Clinical Practice Guidelines in Oncology:
      https://www.nccn.org/professionals/physician_gls/pdf/infections.pdf
    • (¹Ì±¹) The fourth international consensus guidelines on the management of cytomegalovirus in solid organtransplantation:
      https://journals.lww.com/transplantjournal/fulltext/10.1097/tp.0000000000005374~the-fourth-international-consensus-guidelines-on-the
    • (¹Ì±¹) KDIGO 2009 clinical practice guideline for the care of kidney transplant recipients (chapters 12~14):
      https://kdigo.org/guidelines/transplant-recipient/
  • ¸Å°³Ã¼ °¨¿°º´
    • (±¹³») 2026³âµµ ¸»¶ó¸®¾Æ °ü¸®Áöħ:
      https://www.kdca.go.kr/preview/doc.html?fn=temp_1773306173243100&rs=/atchmnfl/preview/result/
    • (±¹³») ÀÇ·áÀÎÀ» À§ÇÑ ¸»¶ó¸®¾Æ ¿¹¹æ ¹× °ü¸® ¾È³»¼­:
      https://www.ulsancidc.or.kr/kor/?pCode=MN0000019&pg=4&mode=view&idx=1977
    • (±¹³») 2026³âµµ Áøµå±â¡¤¼³Ä¡·ù¸Å°³°¨¿°º´ °ü¸®Áöħ(ÂêÂê°¡¹«½ÃÁõ,ÁßÁõ¿­¼ºÇ÷¼ÒÆÇ°¨¼ÒÁõÈıº,½ÅÁõÈıºÃâÇ÷¿­):
      https://www.kdca.go.kr/preview/doc.html?fn=temp_1772778802875100&rs=/atchmnfl/preview/result/
    • (±¹³») 2026³âµµ ¼öÀμº ¹× ½Äǰ¸Å°³°¨¿°º´ °ü¸®Áöħ:
      https://www.kdca.go.kr/preview/doc.html?fn=temp_1767317526858100&rs=/atchmnfl/preview/result/
  • Ç×»ýÁ¦ ½ºÆ©¾îµå½Ê ÇÁ·Î±×·¥(antimicrobial stewardship program)
    • (±¹³») Ç×»ýÁ¦ »ç¿ë°ü¸® ÇÁ·Î±×·¥ ÅëÇÕ ¿î¿µ °¡À̵å¶óÀÎ:
      https://www.kdca.go.kr/sites/kdca/download/ASP%EC%9A%B4%EC%98%81%EC%A7%80%EC%B9%A8.pdf
    • (±¹³») Ç×»ýÁ¦ »ç¿ë°ü¸® ÇÁ·Î±×·¥ÀÇ ±¹³» ½ÇÇàÀ» À§ÇÑ Çٽɿä¼Ò -Á¾ÇÕº´¿ø´ë»ó-:
      https://doi.org/10.3904/kjm.2023.98.1.11
    • (±¹³») 2025³â Ç×»ýÁ¦ »ç¿ë·® ºÐ¼® ¹× ȯ·ù½Ã½ºÅÛ ¸Å´º¾ó:
      https://www.konas.or.kr:44538/xe/pds/1974
    • (¹Ì±¹) SHEA statement on antibiotic stewardship in hospitals during public health emergencies:
      https://doi.org/10.1017/ice.2022.194
    • (¹Ì±¹) Understanding inpatient antimicrobial stewardship metrics:
      https://doi.org/10.2146/ajhp160335
  • [ÁÖ¿ä »çÀÌÆ®]

    • ´ëÇѰ¨¿°ÇÐȸ: http://www.ksid.or.kr
    • ´ëÇÑÇ×±Õ¿ä¹ýÇÐȸ: http://www.ksat.or.kr
    • ´ëÇѰáÇÙ ¹× È£Èí±âÇÐȸ: http://www.lungkorea.org
    • Infectious Diseases Society of America (IDSA): http://idsociety.org
    • AIDSinfo: http://aidsinfo.nih.gov/guidelines